Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nemaura Med Inc (NQ: NMRD )

0.3150 -0.0310 (-8.96%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nemaura Med Inc

< Previous 1 2 3 4 5 Next >
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Enters Commercialization Phase of Corporate Development
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Commercialization Phase of Its Corporate Development, Recognizes First-Ever Revenues
Via Investor Brand Network
Nemaura Medical’s (NASDAQ: NMRD) sugarBEAT(R) CGM Device Met with Early Success
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Revolutionary sugarBEAT(R) CGM Device Met with Early Success
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Recognized as Innovator of the Year
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Recognized as Innovator of the Year, Awarded Top Honors for Innovation in MedTech, Life Sciences
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions Worldwide
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions to Millions of Patients Worldwide
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing, Distribution Scale-Up
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing and Distribution Scale-Up, Commercialization Phase of Growth
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring’s Exponential Growth Rate
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring Sector’s Exponential Growth Rate
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Commences Rollout of Miboko Application
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Launch Leveraging ‘Most Reliable Gateway Toward Wider Adoption of Preventative Health Maintenance Practices’
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura Medical (NASDAQ: NMRD) Appoints Healthcare Specialist Dr. Arash Ghadar as COO
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Appoints Technical Healthcare Specialist Dr. Arash Ghadar as COO
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Marks History-Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks History Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Commences Rollout of Miboko Application
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Launches Miboko – A New Metabolic Health Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Launches Miboko – a New Metabolic Health Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura Medical (NASDAQ: NMRD) Names Industry Veteran as COO
Via Investor Brand Network
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.